ABSTRACT
Objective:To observe the expression levels of small ubiquitinated protein specific protease (SENP) 1 and small ubiquitin-related modifier protein (SUMO) 1 in patients with diffuse large B-cell lymphoma (DLBCL), and analyze the clinical value of evaluating prognosis.Methods:The clinical data of 66 patients with DLBCL (DLBCL group) in Inner Mongolia People′s Hospital from February 2017 to October 2020 were retrospectively analyzed, and 60 cases of healthy people in the same period were selected as the healthy control group. The expression levels of SENP1 and SUMO1 were detected by enzyme linked immunosorbent assay (ELISA). The correlation between the expression levels of SENP1, SUMO1 and clinical characteristics was analyzed. The independent risk factors affecting the prognosis were analyzed by Cox multivariate analysis.Results:The SENP1 in DLBCL group was significantly higher than that in healthy control group (50.39 ± 6.86 vs. 7.47 ± 1.32), the SUMO1 in DLBCL group was significantly lower than that in healthy control group (8.84 ± 2.13 vs. 31.49 ± 5.89), and there were statistical differences ( t = 47.640 and 29.210, P<0.01). There were statistical differences in SENP1 and SUMO1 among patients with different clinical stages ( P<0.01). The expression levels of SENP1 and SUMO1 were correlated with clinical stage and international prognostic index (IPI) ( P<0.05), and were not correlated with age, gender, disease site and clinical symptoms ( P>0.05). The 3-year survival rate in patients with high SENP1 expression (30 cases) was significantly lower than that in patients with low SENP1 expression (36 cases), the 3-year survival rate in patients with high SUMO1 expression (38 cases) was significantly higher than that in patients with low SUMO1 expression (28 cases), and there were statistical differences (26.67% vs. 75.00% and 73.68% vs. 39.29%, P<0.05). Cox multivariate regression analysis result showed that clinical stage, IPI, SENP1 and SUMO1 were independent risk factors affecting the prognosis in patients with DLBCL ( HR = 1.352, 1.487, 2.048 and 3.295; 95% CI 1.180 to 1.691, 1.187 to 1.602, 2.536 to 4.023 and 2.752 to 5.325; P<0.05 or <0.01). Conclusions:In patients with DLBCL, SENP1 is highly expressed and SUMO1 is lowly expressed. The expression levels of SENP1 and SUMO1 are closely related to clinical stage and IPI in patients with DLBCL, and they are independent risk factors of the prognosis.
ABSTRACT
Objective To explore the expression of macrophage migration inhibitory factor (MIF) in renal carcinoma tissue and its effect on invasion of renal carcinoma cell.Methods Forty-eight cases of patients definitely diagnosed with renal cancer in the Department of Pathology,the Inner Mongolia Autonomous Region People's Hospital and Baotou Municipal Tumor Hospital from March 2013 to March 2015 served as the research subjects.The expressions of MIF protein and mRNA in renal carcinoma tissues and adjacent normal tissues,renal carcinoma cell lines and normal renal tubular epithelial cells HK-2 were detected by adopting the Western blot and RT-PCR.siRNA MIF and siRNA NC were transfected into renal carcinoma cells by liposome.The transfection effect was detected by Western blot and RT-PCR.The cell viability and invasion ability were measured by MTT and Transwell method respectively.The expression of hypoxia inducible factor 1-alpha (HIF-1α) and matrix metalloproteinase 9 (MMP9) was measured by Western blot.Results The expression levels of MIF protein and mRNA in renal carcinoma tissues were significantly higher than those in adjacent normal tissues (0.89±0.09 vs.0.18±0.02,1.19±0.04 vs.0.19±0.01,P＜0.05).The expression levels of MIF protein and mRNA in renal cancer cell line ACHN,769-p,786-O,Caki-1 cells were higher than those in renal tubular epithelial HK-2 cells (P＜0.05).Compared with the siRNA NC group,the expression levels of MIF protein and mRNA in siRNA MIF group were significantly down-regulated (P＜0.05),the cell viability and invasion ability were reduced (P＜0.05),and the expressions of HIF-1α and MMP9 were down regulated (P＜0.05).Conclusion MIF is highly expressed in renal carcinoma,downregulating MIF expression can significantly inhibit the renal cancer cell invasion,which might be related with inhibiting HIF-1α/MMP9 signaling pathway.
ABSTRACT
Objective To investigate the clinical value of the combined detection of Golgi protein 73 (GP73),alpha-fetoprotein variant-L3 (AFP-L3)and transforming growth factorβ1(TGFβ1)in the early diagnosis of hepatocellular carcinoma (HCC).Meth-ods 48 cases of healthy control,42 cases of hepatitis B,50 cases of posthepatitic cirrhosis and 58 cases of HCC were selected and detected GP73,AFP-L3 and TGFβ1.The detection results were compared among 4 groups.Results (1)The levels of GP73,AFP-L3 and TGFβ1 had statistical differences among 4 groups(P <0.05 );(2 )The positive rate of the 3-marker combined detection reached 96.55%,which was higher than that of the 2-marker combined detection and the single marker detection.Conclusion (1) GP73,AFP-L3 and TGFβ1 may be used as the serum indicators for the early diagnosis of HCC;(2)Compared with the traditional HCC marker AFP,AFP-L3 has relatively high sensitivity and specificity and has the important role in the differential diagnosis of benign and malignant diseases of the liver,which is considered as a better serum marker in the HCC diagnosis;(3)The 3-indicator combined detection can significantly improve the positive detection rate of HCC and has better application value.
ABSTRACT
Objective To evaluate the clinical value of combined treatment for spontaneous intraventricular hemorrhage. Methods 26 patients with spontaneous intraventricular hemorrhage were conducted on the whole turn of low lateral drainage of bilateral urokinase infusion therapy, supplemented by lumbar puncture cerebrospinal fluid replacement. Results The total effective rate was 84.62% ,mortality rate was 15. 38%. Conclusion Bilateral lateral drainage of alternating low urokinase infusion,supplemented by lumbar puncture cerebrospinal fluid replacement was effective in treatment of spontaneous intraventricular hemorrhage. It could reduce mortality in patients with intraventricular hemorrhage and increase the patients' prognosis.